Registration for a live webinar on 'Chronic inflammation, immune cell trafficking and anti-trafficking agents' is now open.See webinar details
Dr. Michael Retsky Harvard TH Chan School of Public Health, USA1 Talk
Michael Retsky received PhD in physics from University of Chicago and worked in experimental physics at Zenith Electronics and Hewlett-Packard. After making a career change into cancer research 30 years ago, he was Prof of Biology at University of Colorado and visiting Prof at University of Texas. Michael’s current area... read moreof interest is to study cancer using computer simulation. He was the first person to use what is now called metronomic chemotherapy for stage IIIc colon cancer in 1995-1997.